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Antigen recognition of B cells is a  result of the binding of specific membrane Ig to 
antigens  alone,  whereas  T  cell  recognition seems to follow different  rules.  Since the 
discovery of Zinkernagel and Doherty (1), Shearer et al. (2), and Bevan (3) that mouse 
cytotoxic T  lymphocytes  (CTL) 1 activated  against  virus,  the  hapten  2,4,6-trinitro- 
phenyl  (TNP),  and  minor  histocompatibility  antigens  recognize  the  antigens  in 
conjunction with self-histocompatibility determinants,  major histocompatibility com- 
plex  (MHC)-  restricted  recognition  has been regarded  as a  general  phenomenon  of 
the T  cell-recognition process. Accordingly, MHC restriction was also seen with helper 
T  cells  (TH), T  cells performing delayed-type hypersensitivity  (DTH)  (TDTn), and T 
cells proliferating against polypeptide antigens in vitro (4-6). 
To  explain  MHC  restriction,  two  basic  models  have  been  proposed:  the  one- 
receptor  model  postulates  one  single  type  of T  cell  receptor  (TcR)  that  binds  to 
neoantigenic  determinants  (NAD)  formed  by association  of the  antigen,  e.g.,  virus, 
TNP,  etc.,  with  MHC  antigens,  whereas  the  two-receptor  model  postulates  two 
different types of TcR, one for the antigen, and the other for syngeneic MHC antigens 
(7).  From the  available  experimental  evidence,  a  final  conclusion on the validity of 
either one of the two models cannot be made. Therefore, we tried a  new approach to 
this problem by raising antisera against the receptors of H-2-restricted T  cells. 
* Supported in part by the National Institutes of Health (Bethesda, Md.) contract NOI-CB-74179. 
1 Abbreviations used in this paper: a, anti; AKRTNBC, lymph node cells from 2,4,6-trinitrophenylchloride- 
sensitized mice; AKRa (AKRaAKR-TNP),  AKR anti-(AKR  anti-trinitrophenylated  AKR);  aid,  anti- 
idiotypic antiserum(a); ATC, activated T cells; B6, C57BL/6; Bid, idiotypes defined by antibodies to B 
cell receptors; C, complement; CDL, complement-dependent lysis; CML, cell-mediated lympholysis; Con 
A, concanavalin A; CTL, cytotoxic T lymphocytes; DTH, delayed-type hypersensitivity; FCS, fetal calf 
serum; FITC, fluoreseein isothiocyanate(-conjugated); HBSS, Hanks' balanced salt solution; HS, human 
serum; Id, idiotype(s); LU33, number of cells per 106 cytotoxic effector cells which give 33~7~ lysis in CML 
with 104 target cells per well; KLH, keyhole limpet hemocyanin; MHC, major histocompalibility complex; 
MLR, mixed-lymphocyte  reaction(s); NAD, neoantigenic determinant(s); NMS, normal mouse serum; NP, 
(4-hydroxy-3-nitrophenyl)acetyl; R, responders; RaMIg,  rabbit  anti-mouse immunoglobulin antiserum: 
RBC, red blood cells; S, stimulators; SRBC, sheep red blood cells: TcR, T cell receptor(s); TDTH, T cell(s) 
performing DTH; Tn, T helper cells; TId, Id defined by antibodies to T cell receptors; TNCB,  2,4,6- 
trinitrophenylchloride; TNBS, trinitrobenzene sulfonate; TNP, 2,4,6-trinitrophenyl. 
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At the present stage of technology, specific antibodies are the major tool for receptor 
isolation and characterization. This includes antibodies to variable-region-associated 
idiotypic determinants. The most common way to prepare anti-idiotype (Id) antisera 
(aid) is with specific antibodies as immunogens  (8), but antigen-specific T  cells have 
also been  used  to raise aid against TcR  (8-12).  The  latter approach  is particularly 
justified if T  cells had different or additional Id (Id defined by antibodies to T  cell 
receptors [TId]) compared to Id on antibodies of the same specificity (Id defined by 
antibodies to B  cell receptors [Bid]). 
Previously, the method of injecting alloantigen-activated T  cell blasts into syngeneic 
or  semisyngeneic  recipients  has  successfully  been  used  to  raise  aid  against  Id  on 
alloreactive T  cells (11, 12). By following a similar immunization protocol, we describe 
in  this  paper  a  novel  system  for  defining  receptors  on  H-2-restricted  AKR  anti- 
(a)AKR-TNP CTL by aid. This new approach may help to elucidate the diversity of 
the T  cell repertoire, the structure of receptors on H-2-restricted T  cells, the question 
of whether  the one- or two-receptor model is correct, the identity or nonidentity of 
TId and Bid, and finally, which genes code for antigen receptors on T  cells. 
Materials  and  Methods 
Animals.  AKR/J (H-2k), C57BL/6  (B6)  (H-2b), and SJL/J (H-2  s) mice were used. 
Media.  The  culture medium  was  10  mM  of Hepes-buffered  RPMI-1640  (Grand  Island 
Biological Co., Grand Island, N. Y.), supplemented with L-glutamine (2 mM final concentra- 
t!on), streptomycin (100 ~g/ml), 5% human serum (HS), and 2-mercaptoethanol (3 ×  10  -5 M 
final concentration).  The  medium  used  for  the  preparation of cell suspensions and  for the 
washing of cells was the same, except that it did not contain 2-mercaptoethanol. The concen- 
tration of HS in this medium was 2.5%  (wash medium). 
Immunofluorescence was performed in Hanks' balanced salt solution (HBSS) with 10% heat- 
inactivated fetal calf serum (FCS) and  10  -2 M  sodium azide. 
Immunization  of Mice  against 2,4,6-Trinitrophenylchloride (TNCB).  Mice  were  immunized 
against TNCB by sensitization of the abdominal skin by simultaneous application of 20/11 30% 
TNCB in acetone at two different sites in a modification of a procedure that has been described 
(13,  14). 5 d after immunization, the cells from the draining inguinal and axillary lymph nodes 
were put into culture. 
Immunization of  Mice against Fluorescein  Isothiocyanate (FITC).  Mice were injected intravenously 
with 2 ×  107 irradiated (3,000 rad) FITC-coupled syngeneic spleen cells. Spleen cells from these 
mice were restimulated in vitro 14 d after immunization by a modification of the procedure of 
Pohlit et al. (15). 
Cell Preparation  for Cultures.  Lymph node cells from axillary, cervical, inguinal, and mesen- 
teric nodes were prepared and coupled as described previously (16). Mixed lymphocyte reaction 
(MLR) cultures were set up as described (16);  where indicated, responder cells in MLR were 
enriched for T  cells by passing normal lymph node cells over nylon-wool columns (16,  17). 
Culture of Cells  from TNCB-sensitized Mice.  Cells from inguinal and axillary lymph nodes from 
TNCB-sensitized mice were put into culture at a concentration of 5 ×  106/ml in a total vol of 
4  ml in  30-ml Falcon bottles (No.  3012;  Falcon Labware, Div. of Becton, Dickinson & Co., 
Oxnard, Calif.). The bottles were cultured in an upright position in a  5% CO2  and 95%  air 
humidified atmosphere. 
Restimulation In Vitro of  Cells  from FITC-immunized Mice.  Spleen cells from mice 14 d previously 
injected with syngeneic FITC-coupled spleen cells (responders [R]) were restimulated in vitro 
by 3,000-rad-irradiated FITC-coupled syngeneic spleen cells (stimulators IS]) for 5 to 7 days. R 
were at a  cell concentration of 4 ×  106/ml, and S at one of 1 ×  106/ml  (4-ml cultures). The 
incubation was done in the same way as for cells from TNCB-sensitized mice. 
Mitogen Activation.  Spleen cells (5  ×  106 cells/ml) after lysis of erythrocytes (RBC)  were 
stimulated for 2 d with 5 p.g concanavalin A  (Con A; No.  15237;  C. F. Boehringer and Sons, 
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Preparation  of Blasts.  Blasts were recovered from cultures  by centrifuging 5  ml of cultured 
cells over a 4-ml Ficoll-Urovison layer (density:  1.077  g/cma; Schering-Kahlbaum AG, Berlin, 
Federal  Republic of Germany)  in siliconized  12-ml  glass  tubes  at  600 g  for  15  min  at  room 
temperature.  Cells (at  least  95%  viable) were recovered from the interface and  washed  three 
times in medium. Usually, 85% of the viable cells obtained from the allogeneic cultures on day 
5 were large- and medium-size blasts.  Blast cells were defined as cells with a  diameter at  least 
twice that  of a  small lymphocyte, with a  smaller nucleus:cytoplasm  ratio than small lympho- 
cytes, and with a  nonsegmented nucleus (as distinct from nonlymphoid cells). 
T~ypsin  Treatment  of T  Cell Blasts.  The T  cell blasts were washed  twice in RPMI- 1640 with 
0.03 M  Hepes and 5% heat-inactivated FCS (Gibco Diagnostics, Gibco Invenex Div., Labora- 
tory Park, Chagrin Falls, Ohio), counted, washed once more in RPMI-t640  medium without 
serum or Hepes, and  resuspended  in HBSS to a  concentration  of 2  ×  10 7 cells/ml. An equal 
volume of phosphate-buffered  saline  that  contained  5  mg/ml  tosyl-L-phenylalanyl-chlorme- 
thane-treated  trypsin  (Merck  AG,  Darmstadt,  Federal  Republic  of Germany)  was  added  to 
0.2-1  ml of each  cell suspension,  and  the  mixture was  then  incubated  at  37°C  for  30  min. 
Ice-cold RPMI-1640 medium  (10 ml) with  15% FCS was added  to stop the reaction; the cells 
were counted, and washed three times. To enable them to recover from trypsin treatment,  the 
T  cell blasts were cultured at a concentration of 5 ×  10  ~ cells/ml overnight at 37°C, in 5% COz 
and 95% air humidified atmosphere in fresh culture medium in Falcon flasks  (No. 3012). 
Determination  of[aH]Thymidine  Incorporation.  200 #1 of cell suspensions from cultures in bottles 
was transferred  in triplicates to round-bottomed  microtiter plates  (7601305;  Linbro Chemical 
Co., Hamden, Conn.). 2.5 ~Ci of [3H]thymidine (2 Ci/nmol; Radiochemical Centre, Amersham, 
England)  in 5 #1 culture medium was added and [aH]thymidine incorporation over a period of 
8 h was determined. 
Lysis of RBC.  RBC in the pellet from a spleen cell suspension were lysed for 2 min at room 
temperature by the addition of 1 ml of a solution of nine volumes 0.83% NH4CI and one volume 
0.17  M  Tris  (pH  7.5).  After lysis, the remaining cells were washed  three  times and  used  for 
mitogen stimulation or immunization. 
Coupling of TNP or FITC to Cells.  Spleen cells after lysis of RBC were incubated  for  10  15 
min at  37°C in phosphate-buffered  saline  (pH  7.2  for trinitrobenzene  sulfonate  [TNBS]  and 
pH 9.0 for FITC) containing  10 mM TNBS or  100 #g FITC/ml, respectively. After coupling 
the cells were thoroughly washed three times. When Con A-activated T  cells were prepared as 
target  cells for cell-mediated lympbolysis  (CML),  they were  first  labeled  with 51Cr and  then 
with TNP or FITC, respectively. 
TNP  was  coupled  to  sheep  RBC  (SRBC)  according  to  Rittenberg  and  Pratt  (18).  The 
number attached to TNP as an index (see below) refers to the amount of TNBS in mg used for 
coupling (for cells) or the number of TNP groups coupled to a  protein. 
Standard 51Cr-release Assay.  To test the lytic activity of CTL populations we used a standard 
51Cr-release assay. Briefly, 100/~1 CTL at various cell concentrations were incubated in (Linbro 
7601305)  round-bottomed  microtiter plates  with  100/11  51Cr-labeled  Con A-activated  target 
cells. Before incubation, the cells were centrifuged for 5 min at 35 g. The incubation time was 
4 h at 37°C in a humidified incubator at a  5% CO2 and 95% air mixture. After the incubation, 
the supernates  from triplicate cultures were harvested after centrifuging the cells for 10 rain at 
130 g  and  were counted  in a  y-counter  (Packard,  Frankfurt,  Federal  Republic of Germany). 
Low controls were taken from cultures with target cells and medium alone. High controls were 
from cultures frozen and thawed three times. The specific 51Cr-release was calculated according 
to the formula: 
specific release (percent) 
counts per minute experimental release -  counts per minute low control 
×  100. 
counts per minute high control -- counts per minute low control 
The number of cells per  106 cytotoxic effector cells which gave 33~7~ lysis in CML with  104 
target  cells  per  well  (LU3~)  were  calculated  according  to  a  standard  logarithmic  curve  fit 
program  (Texas  Instruments  STI-11;  Texas  Instruments  Inc.,  Digital  Systems,  Houston, 
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LUz3 of the NMS control were taken as 0% inhibition to determine the inhibition of CML 
by CDL with aid. 
Normal Mouse Sera (NMS).  Normal AKR sera were a pool ofsera from 20-30 mice. All sera 
were heat-inactivated (56°C for 30 min) and absorbed on 2-d Con A-activated spleen cells (100 
#1 serum and 2 ×  10  7 cells). 
aThy-l. 1 Antiserum.  C3H  aThy-l.l  AKR  antisera  were  raised,  absorbed,  and  tested  for 
specificity as previously described (19). 
aid.  The principle of the production  of aid was the injection of enriched TNP-activated 
AKR T  cell blasts intraperitoneally into syngeneic AKR mice. The enriched T  cell blasts were 
washed  five times in  10 ml HBSS. At  1- to 4-wk intervals, each mouse received at  least three 
injections. The first injection was in complete, and the subsequent injections were in incomplete, 
Freund's  adjuvant.  Individual  bleedings  from  10-20  mice  were  pooled.  Accordingly,  the 
following sera were raised. First group of mice: (a)  injection: 7 ×  105 cells/mouse; (b) injection: 
3.2 ×  106 cells/mouse (1-wk interval);  (c)  injection: 3 ×  106 cells/mouse (2-wk interval). AKR 
anti-(AKR anti-AKR-TNP)  [AKRa (AKRaAKR-TNP)] antisera  No. 48 were obtained 3 wk, 
No. 51  5 wk, and No. 52 6 wk after the third injection. Second group of mice: (a)  injection: 2.5 
×  106 cells/mouse; (b) injection: 2 ×  106 cells/mouse (2-wk interval); (c) injection: 3 ×  106 cells/ 
mouse (4-wk interval). Antiserum No. 62 was obtained 5 wk after the third injection. 
Absorption of aid.  The antisera (at a predetermined dilution in HBSS) were mixed with cells 
resuspended  in a  known  volume of HBSS. The mixture was incubated  for 30 min on ice, the 
cells centrifuged for  10 min at  16,000 g, and  the serum was recovered. The dilution was then 
calculated. 
aTNP Keyhole Limpet  Hemocyanin (KLH)  Antiserum.  AKRaTNP-KLH  antisera  were raised 
by repeated  intraperitoneal  injection of 50-100/~g TNPaT8  KLH/mouse into AKR mice. The 
first  injection was  in complete,  and  three additional  injections were in  incomplete,  Freund's 
adjuvant.  Individual bleedings from  15 mice were pooled and tested for hemagglutination on 
TNPs0-SRBC. 
Purification ofaTNP Antibodies.  Briefly, AKRaTNP-KLH  antiserum pools with a hemagglu- 
tination  titer  >10 -3  on  TNPs0-SRBC  were  mixed  and  aTNP  antibodies  were  purified  on 
TNPl0-bovine  serum  albumin-coupled  Sepharose  4B  (Pharmacia  Fine  Chemicals,  Div.  of 
Pharmacia,  Inc., Piscataway,  N.J.)  (20). 
Absorption of aid on AKRaTNP-KLH Antisera.  100/11  of aid was mixed with  100  #1  packed 
AKRaTNP-KLH-antiserum-coupled Sepharose 4B (0.8 ml of antiserum and 2.7 g of cyanogen- 
bromide-activated Sepharose 4B). Absorption was performed for 1 h at 4°C. The absorbed aid 
was recovered by centrifugaton of the mixture at  16,000 g  for 10 rain. 
CDL of CTL  by aid.  3  ×  106  cells from  a  CTL  effeetor cell  population  in  RPMI  1640 
medium  that  contained  2%  FCS  were  sequentially  incubated  with  the  following  reagents 
prediluted  in the same medium  (ai  aid  (30 min  at  4°C),  (b)  rabbit  anti-mouse  Ig antiserum 
(RaMIg)  (30 min at 4°C), and  (c) rabbit  complement  (C) with  10 -3 M  sodium azide (30 min 
at 37°C). After the first two incubations,  the cells were washed  twice (10 min at  4°C, 400 g), 
and after the last incubation three times with normal tissue culture medium to remove sodium 
azide (10 min at room temperature, 400 g). Subsequently, the depression of lytic activity versus 
the NMS control was  determined  in a  standard  5~Cr-release assay,  aid was used at  1:18 and 
RaMIg at  1:300  final dilution.  Killer:target cell ratios in the Figures and Tables refer to cell 
counts from the NMS control. 
Immunofluorescence.  The cells were washed three times in fluorescence medium at 4°C, and 
were kept throughout  in this medium. They were resuspended  in  100/~1 of medium to which 
100 #1 of the appropriate antiserum was added  (at a predetermined dilution), incubated at 4°C 
for  30  min,  and  washed  three  times  between  each  incubation.  After  the  final  antiserum 
treatment, the cells were washed three times and mounted on glass slides: the preparations were 
scored  under  a  Zeiss  fluorescence  microscope  (Photomik  III;  Carl  Zeiss,  Inc.,  New  York). 
Staining with the appropriate mouse antiserum was detected by FITC F(ab')2 sheep anti-mouse 
Ig. The anti-Ig antibodies  were raised  and  conjugated  with  fluorochromes as described  (16), 
with the modification that  affinity-chromatography-purified  F(ab')2  fluorescent  anti-Ig anti- 
bodies were used. All sera as well as fluorescent conjugates were centrifuged at  16,000 g  for  10 
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Radiolabeling of Antibodies.  Radiolabeling  with  12~I and  determination  of  radioactivity  of 
sheep  anti-mouse  Ig and  AKRaTNP  antibodies  were performed  according  to  the method  of 
Greenwood et al. (21). 
Results 
The Experimental System.  To  raise  aid  against  Id  on  receptors  of H-2-restricted 
CTL,  we  chose  the  following  experimental  system.  AKR  mice  were  immunized 
against  the  hapten  TNP  by  sensitization  of  the  abdominal  skin  with  the  TNP 
derivative  TNCB.  Subsequent  (5  d  after  sensitization)  in  vitro  culture  of the cells 
from the draining axillary and inguinal lymph nodes without antigen restimulation 
resulted  in cell  proliferation  and the generation of H-2-restricted  AKRaAKR-TNP 
CTL. 
Fig.  1 shows that extensive proliferation as detected by [3H]thymidine incorporation 
and  blast-cell  count  could  only  be  observed  in  cultures  of lymph  node  cells  from 
immunized, and not from unimmunized, mice. The peak proliferative response in our 
cultures varied between day 5 and 7 of culture and depended mainly on the batch of 
HS  used  as  the xenogeneic serum  source.  Usually,  >90%  of the cultured cells  and 
>95%  of the blast  cells were  T  cells as determined  by indirect  immunofluorescence 
with aThy-1.1  antiserum  (data not shown). 
The  time-course  of the ensuing cytotoxic  response  was  concordant  in  magnitude 
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Fro.  1.  Proliferation  in culture of cells from draining lymph nodes from unimmunized AKR mice 
and AKR mice sensitized  on the abdominal skin by TNCB.  Blast  cells  in cultures  of lymph node 
cells from unimmunized (©), and immunized (O) mice.  [3H]thymidine  incorporation  in cultures  of 
lymph node cells from unimmunized (A), and immunized (A) mice. PETER  H.  KRAMMER, RAINER REHBERGER, AND KLAUS EICHMANN 
TASX.~  I 
Enrichment of AKRaAKR-TNP CTL from Cultures of Lymph Node Cells 
from AKR Mice Sensitized by TNCB 
Target cells 
Percent specific SlCr release on day 5 of culture* 
Separated over Ficoll 
Unseparated  Interphase killer:  Pellet  killer:target 
target ratio  ratio 
10:1  5:1  10:1  5:1 
AKR  0  3  6  3  -  1  1 
AKR-TNP  20  15  42  28  8  5 
* CTL: AKRaAKR-TNP. 
1171 
with blast-cell proliferation  (data not shown). Table I shows that AKRaAKR-TNP 
CTL  on  day  5  of culture  could  almost  entirely  be  recovered  in  the  interphase 
containing viable l~last cells after separation of the cultured cells over Ficoll-Hypaque, 
whereas  hardly  any  CTL  could  be  found  in  the  pellet.  CML  obtained  with  the 
interphase  cells  was  a  T  cell  response,  i.e.,  sensitive  to  CDL  with  anti-Thy-l.1 
antiserum ([13,  14]; data not shown), with specificity for syngeneic AKR-TNP target 
cells, i.e., in most experiments, target cells not coupled with TNP or allogeneic TNP- 
coupled  target  cells  were  not  lysed  (Fig.  2).  Occasionally,  H-2  restriction  was  not 
complete and lysis of B6-TNP target cells with TNCB-sensitized AKR CTL could be 
observed. In line with experiments reported by Starzinski-Powitz et al.  (13)  experi- 
ments to map the relevant restriction antigens within the H-2 complex indicated that 
the CML was H-2K  k restricted  (P.  H. Krammer, R.  Rehberger, and K. Eichmann. 
Manuscript in preparation.). 
To raise antisera against Id on receptors of H-2-restricted CTL, we enriched blast 
cells from AKRaAKR-TNP cultures at the time of peak CTL response and repeatedly 
injected these cells into syngeneic AKR mice. Antisera were obtained from bleedings 
starting  3  wk  after  at  least  three  immunizations  and  are  referred  to  as  AKRa 
(AKRaAKR-TNP). In an initial screening, we tested the activity of these antisera in 
indirect  immunofluorescence on blast cells enriched for CTL. For our main method 
of analysis  however, we  thought  it  might  be particularly  important  to  test  AKRa 
(AKRaAKR-TNP) in functional assays. We therefore used a  two-stage CDL test by 
which we could eliminate CTL.  In this assay, cell populations that contained CTL 
were sequentially  incubated  with  AKRa  (AKRaAKR-TNP),  RaMIg, and  selected 
rabbit C. RaMIg was used as an enhancing serum in case AKRa (AKRaAKR-TNP) 
contained non-complement-binding antibodies. This made it necessary to add rabbit 
C  in  sodium  azide  to  stabilize  the  membrane. After  CDL,  we  determined  the 
remaining cytolytic activity of the CTL populations in comparison to CTL popula- 
tions treated with NMS instead of AKRa (AKRaAKR-TNP). 
Reactivity of  AKRa (AKRaAKR-TNP) with AKRaAKR-TNP CTL.  Tested in indirect 
immunofluorescence,  all  AKRa(AKRaAKR-TNP)  reacted  with  AKRaAKR-TNP- 
CTL-containing cell populations to a similar degree as described in Table IV, lines 3 
and 4, i.e., ~70% of all cells were positive with an immunofluorescent intensity that 
varied from fair to strong, whereas the same antisera showed no immunofluorescence 1172  IDIOTYPES  ON  CYTOTOXIC  T  LYMPHOCYTES 
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FIG.  2.  Specificity of CML by CTL  from cultures (day 5) of draining lymph nodes from AKR 
mice sensitized on the abdominal skin by TNCB on different Con A-activated target cells.  AKR 
(O), AKR-TNPI0 (O), SJL-TNP10  (A), and B6-TNP10 (A) target cells. 
TABLE  II 
Inhibition of CML by Removal of CTL Effector Cells with AKRa (AKRaAKR-TNP) Antisera in 
CDL 
Cell population 
CTL  Target Cells 
CDL of CTL 
with AKRa  Depression of cell 
Inhibition  numbers after 
(AKRaAKR-  of CML*  CDL of CTL- 
TNP) antise-  containing cells:~ 
rum No. 
%  % 
AKRaAKR-TNP  AKR-TNP  48  57  48 
51  57  33 
52  90  43 
62  9 l  30 
AKRaB6  B6  48  0  0 
52  0  0 
62  0  0 
AKRaAKR-FITC  AKR-FITC§  48  0  9 
52  0  10 
62  0  0 
* Inhibition of CML after CDL with aid was calculated from LUz3 of the NMS control taken as 0% 
inhibition. 
:~ Depression of cell numbers after CDL with aid was calculated from the NMS control taken as 0% 
depression. 
§ The data in this group are from separate experiments with reagents that had been distributed in 
aliquots. 
on  normal  lymph  node  cells  above  background  with  the  alg  control.  In  addition, 
CDL  with all AKRa  (AKRaAKR-TNP)  consistently depressed between  55 and  95% 
of TNP-specific  AKR  CML  in comparison  to  the NMS  control.  The  activity of the 
antisera resided  in  the Ig fraction.  Table  II  (lines  1,  2,  3,  and  4)  and  Figs.  3 A,  4  A, 
and  5 A  show  the results of representative  experiments  with  the antisera  No.  48,  51, PETER  H. KRAMMER,  RAINER REHBERGER, AND KLAUS EICHMANN  1173 
7o -  A  7o-  B 
60- 
50- 
~3 
40- 
.o 
30- 
20- 
10- 
60- 
50- 
40- 
o,~A  30- 
,::..o t  lo 
5  ,o  4 
killer:target cell ratio 
f 
i  [ 
8  16 
Flo.  3.  Specificity  of AKRa (AKRaAKR-TNP) No. 48 as tested by CDL on AKRaAKR-TNP 
(A); and AKRaB6 CTL (B). (O) NMS control, (O) aid No. 48 unabsorbed, and (A) aid No. 48 
absorbed on AKRaB6 ATC (50 #1 antiserum, 0.8 ×  107 ATC). 
52, and 62, respectively. It can be seen in Table II that even though the inhibition of 
CML ranged  between  55  and  95%  and  the  number of immunofluorescent-positive 
cells was -70%  (Table IV), only 30-50% of AKRaAKR-TNP-CTL-containing cells 
were actually lysed by CDL. 
Specificity of AKRa  (AKRaAKR-TNP) for AKRaAKR-TNP  CTL.  Because we  had 
shown that AKRa (AKRaAKR-TNP) reacted with AKRaAKR-TNP CTL, it had to 
be established  whether  this  reaction  had  specificity. Therefore,  we  tested  whether 
AKRa (AKRaAKR-TNP) had activity for other CTL from the same responder strain 
AKR activated by different antigens, i.e., B6 and AKR-FITC. 
It is evident from Fig.  3 that antiserum No. 48 contained a  marginal but perhaps 
significant  activity against  AKRaB6  CTL which  could  effectively be absorbed  by 
AKRaB6 MLR-activated T  cells (ATC) without  a  major depression of the relevant 
antiserum reactivity against AKRaAKR-TNP CTL. Antisera No. 52 and No. 62 were 
completely nonreactive with AKRaB6 CTL in  repeated  experiments  (Fig.  4B  and 
Table II). The  activity of antiserum  No.  62  against  AKRaAKR-TNP  CTL could 
fully be absorbed by AKRaAKR-TNP-activated cells from day 5  of culture  (20 #1 
antiserum  and  107  cells)  (Fig.  5B),  whereas  absorption  with  the  same  number  of 
AKRaB6  ATC left the  activity against  AKRaAKR-TNP  CTL totally unimpaired 
(Fig.  5 C).  Further evidence for nonreactivity of the antisera with alloreactive AKR 
CTL came from experiments described in Fig. 6. AKRTNcB aB6 CTL obtained from 
aB6 in vitro activation of cells from draining  lymph nodes of mice whose skin had 
previously been sensitized by TNCB were not  lysed in CDL by antisera No. 52 and 
No. 62 (Fig. 6A and B). These experiments were strongly supported by the following 
data:  CML and actual cell number of AKRaAKR-TNP-CTL-containing cell popu- 
lations were depressed after CDL with AKRa (AKRaAKR-TNP). This was not the 
case, however, after the same treatment of AKRaB6-CTL-containing cell populations 
(Table II). 1174  IDIOTYPES  ON  CYTOTOXIC  T  LYMPHOCYTES 
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FIG.  5.  Specificity of AKRa (AKRaAKR-TNP)  No. 62  as tested by CDL on AKRaAKR-TNP 
(A-C) and AKRaAKR-FITC CTL (D). (O) NMS control, (0) ald No. 62 unabsorbed, (A) aid No. 
62  absorbed on AKR cells from day-5 cultures of cells from draining lymph nodes of AKR mice 
sensitized on the abdominal skin by TNCB (20 #1 antiserum, 107 cells), and (&) ald No. 62 absorbed 
on AKRaB6 ATC (20 #1 antiserum,  l07 cells). 
More stringent specificity controls were carried out with FITC-specific AKR CTL. 
Like AKRaAKR-TNP CTL, AKRaAKR-FITC CTL were  anti-Thy-l.l-antiserum 
sensitive, H-2K  k restricted, and hapten specific. In our hands, in contrast to data from 
the literature,  AKRaAKR-FITC CTL lysed AKR-FITC and not AKR-TNP target PETER  H.  KRAMMER, RAINER REHBERGER,  AND  KLAUS  EICHMANN  1175 
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F1o. 6.  Lack of reactivity of AKRa (AKRaAKR-TNP)  with AKRTNcB aB6 CTL. These CTL 
were obtained  from draining lymph nodes from AKR mice sensitized on the abdominal skin by 
TNCB and subsequently cultured with B6 stimulator cells. CDL on AKRTNcB aB6 CTL by aid 
(tl), (©) NMS control. (A) aid No. 52. (B) aid No. 62. Target cells in CML were B6. 
cells  (P. H. Krammer,  R. Rehberger,  and K. Eichmann.  Manuscript  in preparation; 
and  [13,  15]).  Significantly,  as shown  in representative  experiments,  all  attempts  to 
demonstrate any appreciable lysis of AKRaAKR-FITC  CTL by AKRa (AKRaAKR- 
TNP)  were negative  (Table  II, antiserum  No.  48;  Table  II and  Fig.  4C,  antiserum 
No.  52; Table II and Fig. 5 D, antiserum  No. 62). These experiments  in conjunction 
with the insignificant depression of cell numbers in AKRaAKR-FITC-containing cell 
populations after CDL with AKRa  (AKRaAKR-TNP)  (Table II) showed specificity 
of the antisera  for AKRaAKR-TNP  CTL.  It should be pointed out that  the experi- 
ments  represented  in  Figs.  4C,  5D,  and  6  were  done  on  a  separate  occasion.  We 
consider this  not critical,  however, because  for each experiment,  different CTL and 
target-cell  populations  had  to  be  tested.  Furthermore,  all  reagents  were  carefully 
aliquoted  and  used  according  to  stringent  standard  conditions.  In  addition,  every 
experiment was done at least three times with very small variation in the results. 
Lack of Reactivity of AKRa  (AKRaAKR-TNP)  with  TNP,  TNP-NAD,  and Processed 
CTL-Receptor-bound TNP-NAD.  After  we  had  established  the  specificity  of AKRa 
(AKRaAKR-TNP)  for TNP-specific AKR CTL, we concluded that the reactivity of 
the antisera  was directed either against  specificity-associated idiotypic determinants 
or, alternatively,  against  TNP determinants  on AKRaAKR-TNP  CTL. TNP deter- 
minants  could hypothetically be present  on CTL membranes  in three  forms:  (a)  as 
the hapten TNP itself,  (b) in association with cell-surface components to create NAD 
(TNP-NAD),  and  (c)  as  CTL-receptor-bound  TNP-NAD  chemically  modified  by 
antigen-processing mechanisms. 
The  following  experiments  were  set  up  to  exclude  the  possibility  that  AKRa 
(AKRaAKR-TNP)  had antibody activity against  the hapten TNP: the antisera  had 1176  IDIOTYPES ON CYTOTOXIC T  LYMPHOCYTES 
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Fro.  7.  Lack  of reactivity of AKRa (AKRaAKR-TNP) No. 62 with B6aB6-TNP CTL as tested 
by CDL. (©) NMS control; (0) aid No. 62. 
no detectable reactivity with TNP-coupled SRBC in hemagglutination or in radioim- 
mune assays using  the  antisera  and  125I-labeled  sheep  anti-mouse immunoglobulin 
IgG as  enhancing  antibodies  (data  not  shown).  Furthermore,  lysis of B6aB6-TNP 
CTL generated  in  the  same way as AKRaAKR-TNP CTL could  not  be obtained 
(Fig.  7).  In  addition,  TNP  determinants  could  not  be  demonstrated  by  indirect 
immunofluorescence (Table III) or CDL (data not shown) with highly concentrated, 
purified AKRaTNP antibodies (hemagglutination titer on TNPsoSRBC:  1.64 X  10  -4) 
on AKRaAKR-TNP CTL that were, however, lysable by AKRa (AKRaAKR-TNP) 
in CDL. 
AKRa  (AKRaAKR-TNP)  did  also  not  react  with  the  TNP-NAD  that  might 
hypothetically have remained on the CTL membrane from the in vivo immunization. 
Fig. 6 shows that AKRTNcB aB6 CTL effector cells were not lysed. These CTL were 
obtained by in vitro aB6 stimulation of lymph node cells from mice sensitized in vivo 
against TNCB under the same conditions  as to generate aTNP CTL.  Furthermore, 
indirect  immunofluorescence  with  TNP-coupled  AKR  lymph  node  cells  was  not 
above the control of Ig-positive cells (data not shown). 
Contaminating  antibodies  against  TNP-NAD  chemically  modified  by  antigen- 
processing cells and bound  to AKRaAKR-TNP CTL receptors were made unlikely 
by the results shown in Table IV. Trypsin treatment  had efficiently removed CTL 
receptors  and,  consequently,  any  possible  remaining  processed  TNP-NAD.  AKRa 
(AKRaAKR-TNP), however, still lysed AKRaAKR-TNP CTL in CDL after resyn- 
thesis of CTL receptors after recovery in overnight culture from trypsin treatment. 
These experiments demonstrate that the activity of AKRa (AKRaAKR-TNP) was 
not  directed  against  TNP.  We  therefore  conclude  that  the  reactivity  is  directed 
towards  antigenic  determinants  associated with  the specificity of AKRaAKR-TNP 
CTL. These determinants are most likely of idiotypic nature. PETER  H.  KRAMMER,  RAINER  REHBERGER,  AND  KLAUS  EICHMANN  1177 
TABLE  III 
Lack of Detection of TNP Determinants on Cells from Cultures* of Lymph 
Node Cells from AKR Mice Sensitized by TNCB 
Indirect immunofluorescence with  Positive cells:~ 
% 
AKRa (AKRaAKR-TNP) antiserum No. 62§  72 
AKRaTNP antibodies[[  0 
* The cells were taken on day 5 of culture. 
:~ Percent positive cells from NMS controls (4-5%) were subtracted. 
§ The antiserum was used at a dilution of 1:18. 
[IThe affinity-chromatography-purified antibodies had  a  hemagglutination 
titer on TNPs0-SRBC of 1.64 ×  10  -4. AKR-TNPI0  lymph node cells  were 
100% positive in indirect immunofluorescence with these antibodies. 
TABLE  IV 
Resynthesis of Receptors on Cells from Cultures Containing AKRaAKR-TNP CTL after Recovery  from 
Proteolytic Digestion with T~ypsin 
Day of 
Cell population*  culture 
Indirect immur~o-  CDL with 
fluorescence with  AKRa 
AKRa  (AKRaAKR- 
(AKRaAKR-TNP)  TNP) antiserum 
antiserum No. 62  No. 62 (percent 
(percent positive  inhibition of 
cells):~  CML)§ 
AKRaAKR-TNP H  4  Untreated  34 
AKRaAKR-TNP  4  After trypsin treatment¶  0 
AKRaAKR-TNP  5**  Untreated  72 
AKRaAKR-TNP  5  Recovered from trypsin treat-  69 
ment:~:~ 
63 
75 
* Cultures  were  set  up  from  draining lymph  nodes  from  AKR  mice sensitized 5  d  previously on  the 
abdominal skin by TNCB. 
~: The percentage of positive cells from the NMS control (4-5%)  was subtracted. 
§ Inhibition of CML after CDL  with aid  was calculated  from  LUs3 of the NMS  control taken as  0% 
inhibition. 
[[ LU~ were 416. 
¶ Directly after trypsin treatment, no CML could be observed at a killer:target cell ratio of 200:1. 
** LUa3 were 3. 
:~:~ LU33 were 8 after recovery from trypsin treatment in overnight culture. 
Synthesis  of Specificity-associated  Determinants  Detected by  AKRa  (AKRaAKR-TNP)  on 
AKRaAKR-TNP  CTL.  To  actually show  that  AKRaAKR-TNP-CTL-specificity-as- 
sociated determinants  detected by AKRa  (AKRaAKR-TNP)  were synthesized by the 
CTL  themselves we submitted  these cells to  trypsin  treatment  to  test  for resynthesis 
of such  determinants  after  recovery  from  enzyme  digestion  in subsequent  overnight 
culture.  Table  IV  shows  that  trypsin  treatment  of  a  cell  population  containing 
AKRaAKR-TNP  CTL  on day 4  of culture  (1  d  before peak CML  activity)  not only 
depressed  the CML  activity to background  level  (Table  IV, footnote ¶),  but  also the 
number  of cells  positive  in  indirect  immunofluorescence  with  AKRa  (AKRaAKR- 
TNP)  from 34 to 0%. After overnight  incubation  (day 5), 69% of cells recovered from 
trypsin treatment  regained immunofluorescent  positivity. This number  was not greatly 
different  from  the  number  of immunofluorescent-positive  cells  of  a  parallel  day-5 
culture  not  submitted  to  enzyme  digestion  (72%).  That  untreated  CTL  as  well  as 1178  IDIOTYPES ON  CYTOTOXIC  T  LYMPHOCYTES 
CTL that had recovered from trypsin treatment on day 5 of culture could be lysed 
almost equally well in CDL by AKRa  (AKRaAKR-TNP)  (depression of CML:  69 
and 75%, respectively) also showed that AKRaAKR-TNP-CTL-specificity-associated 
determinants were resynthesized by the CTL in <24 h. 
It should be pointed out that in this experiment, as in the one described in Table 
III, the number of immunofluorescent-positive cells by far exceeded the number of 
cells which could possibly have been accounted for by cells with cytotoxic function. 
Discussion 
This paper describes a  new system to define specificity-associated determinants on 
TcR of H-2-restricted AKRaAKR-TNP CTL with AKRa (AKRaAKR-TNP)  anti- 
sera  raised  by  immunizing  AKR  mice  with  syngeneic  blast  cells  enriched  for 
AKRaAKR-TNP CTL. Among other possibilities, we chose our experimental system 
to study Id on  H-2-restricted CTL for the  following reasons.  We tried  to limit  the 
number of CTL clones  in  AKRaAKR-TNP-CTL-containing cell  populations  used 
for immunization to more successfully raise aid. Therefore, we used AKRaAKR-TNP 
CTL,  which  are  restricted  mainly  to  the  K  end  of the  MHC,  as  immunogen.  In 
addition, we assumed that skin sensitization of AKR mice by TNCB with subsequent 
in vitro development of AKRaAKR-TNP CTL without  antigen  restimulation  pro- 
vided conditions in which a  limited amount of antigen activates a  restricted number 
of CTL precursor clones. Moreover, we tried to reduce the risk of raising antibodies 
that would  contaminate the desired  aid  activity by using immunization  with  blast 
cells  purified  from dead  cells  and  debris  and  enriched  for AKRaAKR-TNP  CTL 
from  cultures  to  which  no  TNP  had  been  added.  Finally,  because  aid  against 
alloreactive T  cells  had  successfully  been  raised  by  immunization  of syngeneic or 
semisyngeneic recipients with alloantigen-activated T  cell blasts (1 l,  12), we followed 
a  similar protocol  and  used  syngeneic AKR  mice as recipients  for blast  cells  from 
AKRaAKR-TNP-CTL-containing cell populations. 
All of our four tested antisera in the TNP system reproducibly demonstrated strong 
reactivity with  a  substantial  fraction of AKRaAKR-TNP  CTL.  This suggests  that 
they contained  antibodies against  a  limited number of dominant  clonotypes rather 
than against many different AKRaAKR-TNP CTL clones. In comparison, reproduc- 
ible activity of aid  against  alloreactive T  cells could,  in  our hands,  only be shown 
with few antisera and greater experimental difficulties (8).  The reason for this could 
be  that  alloreactive T  cells  comprise a  heterogeneous  mixture  of clones  with  pro- 
nounced variation in the dominant Id. 
In  indirect  immunofluorescence  and  CDL,  AKRa  (AKRaAKR-TNP)  detected 
between  30 and  70% positive cells in AKRaAKR-TNP-CTL-containing cultures on 
the  day of maximal CML  activity.  This  probably exceeds  the  number of CTL  in 
these  cultures  and  suggests  that  the  antisera  also  react  with  other  cells,  possibly 
hapten-specific Tn. 
After we established  that  AKRa  (AKRaAKR-TNP)  reacted  with  H-2-restricted 
AKRaAKR-TNP  CTL,  we  could  demonstrate  that  this  activity  was  specific.  In 
repeated experiments, the antisera did not  react with alloreactive AKR CTL,  H-2- 
restricted  AKR CTL activated by FITC, and  H-2-restricted, TNP-specific CTL of 
strain B6. This would be in line with the observation that AKRaAKR-FITC CTL in PETER  H.  KRAMMER, RAINER REHBERGER, AND KLAUS EICttMANN  1179 
our hands are not cytotoxic for AKR-TNP target cells and apparently have TcR with 
combining sites different from AKRa AKR-TNP CTL. 
Because AKRa (AKRaAKR-TNP) detected specificity-associated determinants on 
AKRaAKR-TNP CTL, it remained to be shown whether this activity was directed 
against idiotypic determinants on AKRaAKR-TNP CTL TcR or against the antigen 
TNP that might hypothetically have persisted on AKRaAKR-TNP CTL membranes. 
We could  exclude  the  possibility that  AKRa  (AKRaAKR-TNP)  reacted  with  the 
antigen TNP alone, TNP in association with lymphocyte-surface components creating 
TNP-NAD,  or  putative  CTL-receptor-bound  TNP-NAD  chemically  modified  by 
antigen-processing mechanisms. We concluded therefore, that the relevant antibodies 
in AKRa (AKRaAKR-TNP) were aid-directed against the idiotypic determinants on 
receptors of H-2-restricted AKRaAKR-TNP CTL effector cells. 
There are two major arguments to be raised against the firm conclusion that our 
antisera  have specificity for Id.  Both  arguments  concern  the  fact  that  the  control 
CTL, which did not react with our antisera, were produced by immunization protocols 
that differ from that used to raise AKRaAKR-TNP CTL. This leads to the possibility 
that in addition to different idiotypes, either different differentiation antigens (viruses, 
blasts,  etc.)  are  expressed  on  the  different  CTL  populations,  or  that  pronounced 
differences exist in clonal idiotypic heterogeneity. In the latter case, even the use of 
the same hapten as stimulator in two different immunization procedures could lead 
to  absence  of  idiotypic  cross-reactivity  between  the  two  CTL  populations.  With 
respect  to  differentiation  antigens,  we  came  to  the  conclusion  that  no  biological 
experiment exists to formally rule out this possibility. We should point out, however, 
that  in  many  similar  immunization  protocols,  antisera  were  obtained  that  were 
formally shown  to react with T  cell receptors  (11,  12).  In the absence of the strong 
experimental evidence of cross-reactivity with antibodies of the same specificity (see 
below), we shall have to use biochemical procedures to eliminate the possibility of a 
differentiation antigen. Such experiments are in progress. Possible differences in clonal 
heterogeneity between FITC- and TNP-specific CTL raised by two different protocols 
could lead to the situation that a  small number of FITC-specific CTL clones would 
express  full  reactivity  with  our  antisera  but  would  escape  detection  in  the  very 
heterogeneous mixture of FITC-specific clones. In this case, we would have to conclude 
that  although  our  antisera  do  not  distinguish  between  some TNP-specific binding 
sites  and  some  FITC-specific  binding  sites,  they  do  distinguish  between  various 
different FITC-specific binding sites.  Also in this case the specificity of the antisera 
had to be defined as idiotypic. 
It has previously been shown that aid raised against alloreactive T  cell blasts could 
partially be absorbed by alloantibodies of the same specificity, indicating that at least 
a fraction of TId was overlapping with Bid (11). We set up similar experiments to test 
whether  Id  defined  on  H-2-restricted  AKRaAKR-TNP  CTL  TcR  by  AKRa 
(AKRaAKR-TNP) were also present on AKRaTNP antibodies. We have extensively 
absorbed  AKRa  (AKRaAKR-TNP)  on  a  pool  of  high-titered  AKRaTNP-KLH 
antisera to subsequently determine the decrease of aid activity on AKRaAKR-TNP 
CTL  in  CDL  and  indirect  immunofluorescence.  We  have  tried  to  competitively 
inhibit (a) CDL by AKRa (AKRaAKR-TNP) of AKRaAKR-TNP CTL by addition 
of  variable  amounts  of  AKRaTNP  antibodies  and  (b)  hemagglutination  by 
AKRaTNP-KLH antiserum of TNPs0-SRBC by addition of variable amounts of aid. 1180  IDIOTYPES ON  CYTOTOXIC T  LYMPHOCYTES 
Finally,  we  tested  the  binding  of 125I-labeled  AKRaTNP  antibodies  to  aid-coated 
microtiter plates (22). The results of these experiments were negative (data not shown). 
This could be explained in a number of different ways. A minor fraction of overlapping 
TId and Bid might have escaped our detection or overlapping TId and Bid might be 
expressed at different time points of the immune response. On the other hand, to be 
able to detect  overlapping TId and  Bid,  it might  be essential  to raise the relevant 
antibodies by skin sensitization of AKR mice with TNCB instead of immunization 
with  TNP-KLH.  This  has  also  been  extensively  tried  but  the  amount  of aTNP 
antibodies  obtained  by  that  procedure  was  negligible.  We  think  that  the  lack  of 
reactivity  with  aTNP  antibodies  is  presently  not  a  serious  argument  against  the 
idiotypic specificity of our antisera and the question  of identical  or nonidentical  Id 
repertoire of T  and B cells needs to be resolved by further experiments. Id on TcR of 
H-2-restricted CTL (TId) and Id on antibodies (Bid)  may be similar or nonoverlap- 
ping, depending on the presentation of the immunizing hapten. One could infer this 
from a comparison of the data by Ando and Kisielow (23)  and by Weinberger et al. 
(24): even though primary anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies from 
H-2  b mice are heteroclitic,  i.e.,  they react  with  higher  affinity with  the  hapten  (4- 
hydroxy-5-iodo-3-nitrophenyl)acetyl (NIP), NP-specific CTL from the same strain do 
not have this Ig-l-allotype-linked, fine-specificity marker that is characteristic for the 
Ig variable region of the heavy chain. In contrast, NP-specific, DTH-reactive T  cells 
of B6  mice were shown  to  possess similar heteroclicity  as  anti-NP  antibodies.  The 
responsible  difference between  the  two  systems may lie  in  the  presentation  of the 
antigen, which was NP on lymphocytes for CTL induction, but NP on soluble proteins 
for DTH and antibody induction. 
The data  in  this paper have to be discussed  with  respect  to expression on AKR 
CTL of one type of receptor for TNP-self-antigens (one-receptor model), two types of 
receptors for the hapten TNP and AKR MHC antigens (two-receptor model), or one 
complex receptor type with two combining subsites  (a combination of the one- and 
two-receptor model). Different sets of single or complex Id could be expressed in each 
case.  That  AKRa  (AKRaAKR-TNP)  did  not  detect  TcR  on  H-2-restricted 
AKRaAKR-FITC  CTL  would  either  support  a  one-receptor  model  or  could  be 
interpreted in the sense that putative anti-self receptors are not immunogenic because 
of their representation on a  large proportion of all T  lymphocytes and are therefore 
not recognized by the antisera. A tentative answer to this question could be provided 
by testing our antisera on AKRaTNP  CTL from chimeric  mice. These serological 
experiments may give an indication, but a final decision on the validity of either one 
of the above models will eventually come from biochemical and genetic experiments. 
To this end,  the fact that  Id detected  by AKRa  (AKRaAKR-TNP)  show strain 
specificity (e.g., AKR CTL are positive and B6 CTL are negative) will enable us to 
study the genetic control of Id expression on H-2-restricted CTL. In conclusion, the 
TNP CTL idiotype system provides us with a new tool to study T  cell recognition, the 
biochemistry of TcR, and the regulation of the generation of H-2-restricted CTL on 
the Id level. 
Summary 
This paper describes the specificity of AKR anti- (a) [AKR anti-trinitrophenylated 
AKR  (AKR-TNP)]  [AKRa  (AKRaAKR-TNP)]  antisera  raised  in  syngeneic AKR PETER H.  KRAMMER, RAINER REHBERGER, AND KLAUS EICHMANN  1181 
mice  against  AKRaAKR-TNP cell  populations  enriched  for  H-2-restricted  aTNP 
cytotoxic lymphocytes  (CTL)  by  blast-cell  isolation.  The  activity  of the  antisera 
resided  in  the  Ig  fraction.  All  antisera  were  shown  to  reproducibly  react  with 
AKRaAKR-TNP-CTL-containing cell  populations  in  indirect  immunofluorescence 
and all removed the major fraction of CTL in complement-dependent lysis causing a 
considerable depression of cell-mediated lympholysis. The antisera were nonreactive 
with alloreactive AKRaC57BL/6 CTL and other H-2-restrieted AKR CTL against 
fluorescein-isothiocyanate-conjugated AKR- target cells. It could be excluded that the 
antisera contained contaminating antibodies against TNP, TNP-neoantigenic deter- 
minants  (NAD), or processed CTL-receptor-bound TNP-NAD, thus demonstrating 
specificity  for  determinants  on  T  cell  receptors  of AKRaAKR-TNP CTL.  These 
receptors were produced by the CTL themselves. 
These  observations  are  interpreted  to  suggest  that  AKRa  (AKRaAKR-TNP) 
antisera contain anti-idiotypic antibodies directed against specificity-associated deter- 
minants (idiotypes) on T  cell receptors of H-2-restricted AKRaAKR-TNP CTL. The 
antisera provide a new tool to study the genetic control of idiotype expression on H- 
2-restricted  CTL,  the  biochemistry of T  cell  receptors,  and  the  regulation  of the 
generation of H-2-restricted CTL on the idiotype level. 
We thank Mrs. Doris Mohr for helpful  technical  assistance, and Doctors Wulf Droege, Ulrich 
Koszinowski, Volker Schirrmacher,  and Markus  Simon for critical discussions. 
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